SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014394
Filing Date
2024-04-12
Accepted
2024-04-12 08:44:49
Documents
15
Period of Report
2024-04-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38214
2 ex99-1.htm EX-99.1 26085
3 ex99-1_001.jpg GRAPHIC 2891
  Complete submission text file 0001493152-24-014394.txt   245322

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ntbl-20240412.xsd EX-101.SCH 3024
5 XBRL LABEL FILE ntbl-20240412_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ntbl-20240412_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3437
Mailing Address 320 HATCH DRIVE FOSTER CITY CA 94404
Business Address 320 HATCH DRIVE FOSTER CITY CA 94404 415-851-2410
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36581 | Film No.: 24840081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)